Jane Street’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-41,600
Closed -$47K 11303
2022
Q1
$47K Sell
41,600
-52,100
-56% -$62.3K ﹤0.01% 9714
2021
Q4
$211K Sell
93,700
-91,200
-49% -$229K ﹤0.01% 8741
2021
Q3
$632K Buy
+184,900
New +$570K ﹤0.01% 6838
2016
Q1
Sell
-10,300
Closed -$81K 4774
2015
Q4
$81K Buy
+10,300
New +$88.7K ﹤0.01% 3827

Other funds holding INFI

Jane Street's INFI Position: Q1 2023 in Review

Jane Street sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2023, closing a stake of 147,550 shares — an estimated $81.9K sold.

Jane Street first reported a position in INFI in Q1 2014 and held it in 9 quarters. The position peaked at $857K in Q3 2021. 53 funds tracked by Wall St. Rank hold INFI as of Q1 2023.

  • Jane Street reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Jane Street sold 147,550 Infinity Pharmaceuticals, Inc. shares in Q1 2023, an estimated $81.9K.
  • Jane Street first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2014 and held it in 9 quarters.
  • Jane Street's Infinity Pharmaceuticals, Inc. position peaked at $857K in Q3 2021.
  • 53 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.